Steven Globerman

Canada’s inflation rate has hit 7.7%, which will undoubtedly spur more sharp interest rate increases by the Bank of Canada in coming months.

For its part, the federal government seems willing to stand aside and not provoke a conflict with the central bank — even if higher interest rates…

“[T]here is no private insurance coverage or out-of-pocket payment for basic health care services in Canada, which distinguishes Canada’s health care system from those of other high-income countries,” said Globerman, who is a professor emeritus at Western Washington University and a senior…

Most of the time, Canada isn’t the biggest target of ire for American politicians. But in a speech to governors on Feb. 26, President Donald Trump took aim at the country’s neighbors to the north, calling out the balance of trade between the two nations.

On trade, …

While health care is a dynamic service characterized by the continual introduction of new drugs and medical devices, physicians remain at the centre of health-care delivery. It is therefore worth noting that Canada lags well behind almost all developed countries in the availability of physician…

The U.S. administration tipped its hand ahead of this week’s NAFTA negotiations in Washington, D.C.

A report released by the Office of the U.S. Trade Representative last month set out, in broad strokes, the administration’s negotiating strategy.

Not surprisingly, the…

Story features WWU's Steven Globerman.

"Stronger patent protections would encourage the development of new drugs and medical devices, which could improve and even save the lives of Canadians," said Steven Globerman, Fraser Institute senior fellow, Kaiser Professor of International Business at…

The regulation of Canada's broadcasting sector by the CRTC is at a crossroads. Technological change, especially the proliferation of streaming video over the Internet, or so-called over-the-top (OTT) broadcasting, is seriously challenging the viability of the regulatory model that's…

A U.S. healthcare services company is poised to become the single largest player in the Canadian retail pharmacy sector, both supplying and selling drugs at retail, a move competitors say will put them at a disadvantage.

“The supplier who supplies me with medicine now competes with me…

Subscribe to Steven Globerman